Fig. 7: Chaetocin inhibits the growth of patient-derived GC xenografts. | Cell Death & Disease

Fig. 7: Chaetocin inhibits the growth of patient-derived GC xenografts.

From: ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin

Fig. 7: Chaetocin inhibits the growth of patient-derived GC xenografts.

NCG mice were subcutaneously inoculated with GC tissues and then treated with vehicle or chaetocin (0.25 mg/kg) for 14 d. a and b tumor volume, and c tumor weight of patient-derived xenografts in NCG mice. d Body weight of the mice. Results were shown as mean ± SD of five mice in each group. *P < 0.05, vs. control group

Back to article page